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Cancer as a chronic disease — a psychological perspective
Monika Paleczna
Cancer is a disease that affects many people. Therefore, issue of proper psychological adaptation to the disease is 
of utmost importance and allows one to look for a better understanding in similar fields. Cancer has many common 
features with chronic diseases, despite the fact that it is not established whether it can be classified as a chronic di-
sease. The first goal of this article is to confirm that according to the WHO definition, cancer indeed can be classified 
as a chronic disease. The second aim is to present implications of this assumption. Knowledge about the functioning 
of patients with chronic disease may be a source of hypotheses for psychological adjustment in cancer. Considering 
cancer as a chronic disease allows application of psychological understanding of chronic diseases to the study of cancer.
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What is a chronic disease?
Suffering from a disease has an impact on both the 
personal and professional life of a patient. When the dise-
ase is acute, the patient has a chance to return to his or her 
previous life after treatment ends. A chronic disease cannot 
be completely cured, but the current level of development 
of medicine makes it possible to live with some diseases for 
many years. Chronic disease is connected with both a clinical 
condition and psychological adjustment. Adjustment to a 
chronic disease concerns changes in various areas of life, the 
passage of time to cope with changes and different ways 
people adapt [1]. A chronic disease has also an impact on 
the economic status of a patient, his or her family, and on the 
economic situation of the society [2]. Therefore, this topic is 
important not only from the clinical or psychological point 
of view, but it is more global. Among well-known chronic 
diseases, we can distinguish primarily chronic coronary 
heart diseases, chronic respiratory diseases and diabetes.
The Centers for Disease Control and Prevention [3] in its 
definition of chronic disease, includes the following crite-
ria: the long-lasting character, a lack of spontaneous cure, 
and no possibility of being completely cured. A broader 
definition is given by WHO [4]. It focuses on the permanent 
character of the disease, residual disability, non-reversible 
pathological alteration, special training of the patient for 
rehabilitation and the necessity of a long-period of super-
vision, observation, or care.
The purpose of the paper is to investigate whether it is 
possible to examine whether cancer meets the conditions 
for chronic disease defined by WHO and, if so, what are the 
psychological consequences.
Cancer as a chronic disease?
Is it permanent?
Cancer is not classified as a disease that can be completely 
cured, but rather it can be at most in remission [5]. The situation 
when a tumor becomes smaller is called “partial remission.” 
However, complete remission does not mean that the cancer 
cells are absent, but that there is no apparent evidence of 
Artykuł w wersji pierwotnej:
Paleczna M. Cancer as a chronic disease — a psychological perspective. NOWOTWORY J Oncol 2018; 68: 28–32.
Należy cytować wersję pierwotną.
30
cancer. Therefore, since the reemergence of cancer is always 
possible, a cancer patient after having completed the treatment 
is required to participate in regular diagnostic procedures The 
risk of recurrence depends on the cancer type [6–9].
Does it result in a residual disability?
Both cancer and the treatment process can cause di-
sability and dysfunctions. Breast cancer may lead to some 
serious changes in the physical functioning of the arm, 
shoulder and hand areas [10]. One in five women suffers 
from lymphedema after having breast cancer [11], which 
decreases the quality of life and increases psychological 
distress [12]. It also restricts the range of motion [13].
Cancer can cause changes in areas related to eating and 
talking. Laryngectomy leads to a loss of voice [14], head and 
neck cancer provokes speaking and swallowing difficulties 
[15]. The voice plays an important role in social life; therefore 
the restoration of voice has a positive impact on patients’ 
well-being [16]. One possible way of rehabilitation is use 
of an artificial larynx [17]. Patients are also encouraged to 
practice some particular types of sport: swimming, water 
aerobics, Nordic walking and cycling [18].
Irradiation may cause erectile dysfunction [19], however 
in testicular cancer patients psychological factors play an 
important role in satisfaction with sexual life [20].
Is it caused by a non-reversible pathological 
alteration?
Cancer cells come from normal body cells [21] and in-
nate immune cells contribute to cancer development [22]. 
It is a non-reversible process. In metastasis, cancer cells 
travel through the blood or lymph system into the tissue 
of another organ, initiate and maintain their growth [23].
Does it require special training of the patient for 
rehabilitation?
Cancer affects the functioning of the individual in many 
areas of his or her life and rehabilitation is often an indispen-
sable element of cancer treatment [24, 25]. For this reason, 
rehabilitation is required in many areas:
Body rehabilitation 
The return to the pre-illness life is associated with motor 
function [26]. A common problem among cancer patients is 
fatigue [27]. Clinically significant levels of fatigue are obse-
rved in 30% patients up to six years after completion of the 
treatment [28]. Fatigue, in turn, may cause a reluctance to 
exercise. Full recovery is possible due to the relatively fast 
return to everyday life [29] and it requires proper motion 
capabilities.
Rehabilitation influences patients’ quality of life [30], 
including the time of palliative care [31, 24]. It relieves both 
physical [32] and psychological pain [33].
Sexual rehabilitation
Sexual rehabilitation is needed to restore satisfying 
sexual function [34] and both women [35] and men [36] 
need it. Couples counseling is one available form of re-
habilitation [37, 38]. Nonetheless, there are no specific 
recommendations for an optimal means of rehabilitation 
in this area [39].
Cognitive rehabilitation
Cancer causes some cognitive changes in patients 
[40–42]. Cognitive rehabilitation improves memory functio-
ning [43], visuospatial functioning [44], processing speed 
[45] or verbal fluency [46] and helps with short-term cogni-
tive complaints [47]. It is especially important for patients 
with brain tumor [48].
Psychosocial rehabilitation
Including psychosocial intervention in a rehabilitation 
program increases the quality of a patient’s life [49] and 
family support improves their ability to cope with stress 
[50]. Korstjens et al. [51] indicate five main areas requiring 
consideration in psychosocial rehabilitation: continuous 
support and information about rehabilitation, psychological 
support, support of the family, improved health and medical 
services and help with financial burdens.
Is it expected that a long period of supervision, 
observation, or care will be required?
Due to the possibility of recurrence, patients remain un-
der a regular observation. For example, they need to follow 
a special diet [52] or stop smoking [53]. The risk of recurrence 
decreases five years after a surgery [54], nevertheless there 
is always the possibility of cancer recurrence. Thus, patients 
experience a fear of recurrence [55, 56] in various types of 
cancer: breast cancer [57, 58], ovarian cancer [59], prostate 
cancer [60, 61], head and neck cancer [62, 63], thyroid cancer 
[64], hematological cancer [65], gastric cancer [66] colorectal 
cancer [67], oral cancer [68]. The fear of recurrence changes 
[69] and it affects the quality of life [62]. There are some 
methods to help patients who experience this fear, e.g. 
cognitive-behavioral therapy [70, 71].
Cancer as a chronic disease
Taking into consideration WHO criteria for chronic dise-
ase, cancer can be classified as a chronic disease.
Each chronic disease is characterized by specific risk 
factors, course of illness, and symptoms. It is an oversimplifi-
cation to consider all the diseases as dependent on the same 
psychological characteristics. However, we can formulate 
hypotheses about the psychological functioning of patients 
suffering from cancer on the basis of knowledge of chronic 
diseases. Therefore, several conclusions from research on 
chronically ill patients will be presented.
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1. There is no cure for a chronic disease, which makes self-
-management programs highly recommended. The me-
dical condition of participants in the programs improves, 
they also acquire healthy habits and their self-efficacy 
rises [72]. Membership in the program also reduces the 
number of visits to the emergency department [73, 
74] and is more effective than the information strategy 
[75]. The self-management program is inexpensive, and 
as such it is more easily available [76]. There are also 
internet-based programs [77]. Being a manager of one’s 
own disease is a crucial factor in enhancing everyday 
coping, so self-regulation is an important element in di-
sease management [78]. The psychological adjustment 
to a chronic disease is possible thanks to maintaining an 
active, proper understanding of the situation, expressing 
emotions, and focusing on potential positive aspects of 
life [79]. There is an important role of working on adapti-
ve cognitive emotion regulation strategies [80]. 
2. For the treatment to be effective, the patient has to be 
aware of the consequences of the disease. In the rela-
tionship between the patient and his or her physician, 
the patient is treated as a partner [81], which means that 
he or she takes responsibility for his or her actions – the 
patient is obliged to engage in various practices inten-
ded to improve his physical condition [82], for instance 
changes in his or her diet, undertaking some physical 
activity, overcoming smoking or drinking habits.
3. Although an optimistic attitude plays an important role 
in the adjustment to a chronic disease, it depends on the 
controllability of the disease [83]. An optimistic attitude 
affects better mood and is a protection against negative 
perception of the illness [84]. What is important, an opti-
mistic attitude does not lead to bias in perception of the 
illness, but increases insensitivity of activities aiming at 
improving one’s own health [85] and influences on heal-
thier behavior [86]. Meanwhile, a less optimistic attitude 
is related to a lower physical and mental health [78]. 
4. A chronic disease changes a person’s self-perception. 
Taking suffering from a chronic disease as a core ele-
ment of oneself decreases self-esteem [87], while be-
lieving in the ability to cope increases self-esteem [88]. 
Younger children [89] and adolescents [90] have lower 
self-esteem in comparison to their healthy peers, which 
in turn may have negative consequences in adulthood 
[91, 92].
5. Loneliness affects many patients suffering from chro-
nic disease, regardless of the exact type of the disease 
[93]. This applies to both younger [94] and older people 
[95]. Loneliness affects not only patients, but also their 
spouses [96]. Thus, it becomes a wider problem in the 
relationship between the patient and the family.
6. Quality of life is a concept that indicates someone’s 
perception of his or her position in his life [97]. The 
perception of illness, attribution and internal locus of 
control may influence the quality of patients’ life [98]. 
Although the disease decreases it [99–100], it may be 
increased by a greater focus on patients’ everyday acti-
vities aimed at improving their health [101].
Limitation
Tritter and Calnan [102] point out that cancer is a particu-
lar kind of a disease: diagnosis of cancer may mean a range 
of different diseases and it involves many medical fields for 
treatment. The authors indicate that the differences are too 
significant, and cancer should not be defined as a chronic 
condition.
In this paper cancer is considered as a chronic disease 
without dividing it into specific types of the disease. Thus, 
features of a chronic disease (and characteristics of psycho-
logical adjustment) can refer not to all, but to certain types 
of the disease.
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